HB THERAPEUTICS, INC.
Biotech · Private
Small-molecule SUMO1 protein degraders for metastatic colorectal cancer treatment
- Grants
- $2.3M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of Small Molecule SUMO1 Inhibitors for Treatment of Glioblastoma | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer | $1,019,583 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer | $979,536 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2612 | XCELL SCIENCE, INC. | — | — |
| 2613 | AEROBYX, LLC | — | — |
| 2614 | TIBA BIOTECH, LLC | — | — |
| 2615 | HB THERAPEUTICS, INC. | — | — |
| 2616 | NuRevelation, LLC | — | $250K |
| 2617 | Impact Proteomics, LLC | — | $250K |
| 2618 | Oxalo Therapeutics, Inc. | — | $250K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Treating Cancerapplication
- Compositions And Methods For Treating Cancergranted
- Heterocyclic SUMO1 Small Molecule Degraders And Use Thereofapplication
- Compositions And Methods For Treating Cancerapplication
- Compositions And Methods For Treating Cancerapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.